Literature DB >> 29144890

Comprehensive analysis of patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody.

Jia Liu1, Li Xu, Zhuo-Lin Chen, Min Li, Huan Yi, Fu-Hua Peng.   

Abstract

Previous research indicated the association between hepatitis B virus (HBV) infection/vaccination and the onset of demyelinating diseases. However, most of these studies were single case reports, and comprehensive data are still scarce. Here we present a comprehensive analysis of 10 patients with neuromyelitis optica spectrum disorder (NMOSD) combined with chronic hepatitis B (CHB) infection and seropositive for anti-aquaporin-4 antibody (AQP4-Ab). Demographic, clinical, laboratory, neuroimaging, outcome, and follow-up data of the 10 patients were retrospectively analyzed. The median age at the onset of NMOSD was 35 years (range 25-43). Nine patients were female (90%). All patients were positive for HBsAg and had been diagnosed with CHB earlier than with NMOSD. One patient had an autoimmune disease. All patients had normal thyroid function. Paresthesia and visual impairment were the most common clinical symptoms. The cerebrospinal fluid (CSF) parameters (protein and glucose) were normal in 10 cases, whereas slightly higher CSF white blood cell count was detected in 3 patients. The brain and spinal cord magnetic resonance imaging findings were abnormal in 8 patients. All patients were treated with hormone and immunosuppressive therapy, and anti-HBV agents. Patients with detectable serum HBV DNA were more prone to liver damage after receiving high doses of corticosteroids. In 8 patients, the symptoms improved before they were discharged. Two patients with optic neuritis (ON) maintained the symptoms. A month later, 1/8 patient had recurrence of symptoms, and one ON patient progressed to NMO. Overall, the characteristics of NMOSD patients with CHB and seropositive for AQP4-Ab are usually nonspecific. Abnormal liver function test results in NMOSD patients should be a warning of possible CHB infection, and the treatment should be modified accordingly.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29144890      PMCID: PMC5826672          DOI: 10.17305/bjbms.2017.2255

Source DB:  PubMed          Journal:  Bosn J Basic Med Sci        ISSN: 1512-8601            Impact factor:   3.363


  40 in total

1.  Azathioprine: tolerability, efficacy, and predictors of benefit in neuromyelitis optica.

Authors:  C Costanzi; M Matiello; C F Lucchinetti; B G Weinshenker; S J Pittock; J Mandrekar; P Thapa; A McKeon
Journal:  Neurology       Date:  2011-08-03       Impact factor: 9.910

2.  Diagnosis and management of chronic hepatitis B in children, young people, and adults: summary of NICE guidance.

Authors:  Grammati Sarri; Maggie Westby; Sarah Bermingham; Grant Hill-Cawthorne; Howard Thomas
Journal:  BMJ       Date:  2013-06-26

Review 3.  Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status.

Authors:  Douglas Kazutoshi Sato; Marco Aurelio Lana-Peixoto; Kazuo Fujihara; Jerome de Seze
Journal:  Brain Pathol       Date:  2013-11       Impact factor: 6.508

4.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

5.  Vaccinations and risk of central nervous system demyelinating diseases in adults.

Authors:  Frank DeStefano; Thomas Verstraeten; Lisa A Jackson; Catherine A Okoro; Patti Benson; Steven B Black; Henry R Shinefield; John P Mullooly; William Likosky; Robert T Chen
Journal:  Arch Neurol       Date:  2003-04

Review 6.  Immunology of neuromyelitis optica: a T cell-B cell collaboration.

Authors:  Meike Mitsdoerffer; Vijay Kuchroo; Thomas Korn
Journal:  Ann N Y Acad Sci       Date:  2013-04       Impact factor: 5.691

7.  The putative acceleration of optic neuritis when combined with chronic hepatitis B.

Authors:  Shuo Zhao; Tingjun Chen; Chunxia Peng; Huanfen Zhou; Hongyang Li; Dehui Huang; Quangang Xu; Shihui Wei
Journal:  J Neurol Sci       Date:  2015-08-29       Impact factor: 3.181

8.  Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

Authors:  Xiaofeng Liang; Shengli Bi; Weizhong Yang; Longde Wang; Gang Cui; Fuqiang Cui; Yong Zhang; Jianhua Liu; Xiaohong Gong; Yuansheng Chen; Fuzhen Wang; Hui Zheng; Feng Wang; Jing Guo; Zhiyuan Jia; Jingchen Ma; Huaqing Wang; Huiming Luo; Li Li; Shuigao Jin; Stephen C Hadler; Yu Wang
Journal:  Vaccine       Date:  2009-09-01       Impact factor: 3.641

9.  Pathogenic T cell responses against aquaporin 4.

Authors:  Maria Pohl; Marie-Therese Fischer; Simone Mader; Kathrin Schanda; Maja Kitic; Rakhi Sharma; Isabella Wimmer; Tatsuro Misu; Kazuo Fujihara; Markus Reindl; Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2011-04-06       Impact factor: 17.088

10.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

View more
  2 in total

1.  Neuromyelitis optica spectrum disorder with active replication of hepatitis B virus and seropositive anti-aquaporin-4 antibody: A case report.

Authors:  Jiaying Lei; Hong Wang
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

2.  Induction of aquaporin 4-reactive antibodies in Lewis rats immunized with aquaporin 4 mimotopes.

Authors:  Irina Tsymala; Magdalini Nigritinou; Bleranda Zeka; Rouven Schulz; Felix Niederschick; Mia Matković; Isabel J Bauer; Michael Szalay; Kathrin Schanda; Magdalena Lerch; Tatsuro Misu; Kazuo Fujihara; Jeffrey L Bennett; Charlotte Dahle; Florence Pache; Paulus Rommer; Fritz Leutmezer; Zsolt Illes; Maria Isabel Leite; Jacqueline Palace; Petra Scholze; Markus Reindl; Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol Commun       Date:  2020-04-15       Impact factor: 7.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.